Modified Diabetes Prevention Program for Obesity, Weight Loss, and Prediabetes

(DPP-TOO Trial)

Overseen by Courtney E Gamston, PharmD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Auburn University

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to demonstrate the efficacy of the diabetes prevention program for the treatment of overweight and obesity within the community pharmacy setting. The long-term goal is to demonstrate the potential to improve diabetes prevention efforts through expanded access to weight loss services provided in community pharmacies.

Research Team

Courtney E Gamston, PharmD

Principal Investigator

Auburn University Harrison School of Pharmacy

Eligibility Criteria

Inclusion Criteria

BMI ≥ 25kg/m2 (23 if Asian)

≥18 years old

Exclusion Criteria

You are pregnant.

Treatment Details

Interventions

• Modified Diabetes Prevention Program Curriculum (Behavioral Intervention)

Participant Groups

Group I: Modified DPP Experimental Treatment 1 Intervention

Participants in this arm will participate in the modified Diabetes Prevention Program curriculum.

Who Is Running the Clinical Trial?

Auburn University

Lead Sponsor

Trials

81

Recruited

14,600+

Dr. Christopher B. Roberts

Auburn University

Chief Executive Officer since 2022

PhD in Chemical Engineering from the University of Notre Dame

Dr. Fred Kam

Auburn University

Chief Medical Officer since 2005

MD from the University of Alabama at Birmingham